CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label Phase 2 Study to Assess Safety and Clinical Effects of UX007 in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01886378
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:49.511354+00:00
Published At: 2021-02-11T00:00:00+00:00
Record Updated At: 2021-02-11
Results Posted At: 2021-02-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)", "Carnitine Palmitoyltransferase (CPT II) Deficiency", "Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency", "Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency", "Trifunctional Protein (TFP) Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-11"
protocolSection.identificationModule.nctId: "NCT01886378"
protocolSection.identificationModule.officialTitle: "An Open-label Phase 2 Study to Assess Safety and Clinical Effects of UX007 in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-02-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.